Tilray | TRLY - 流动资产

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 5.63B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	流动资产	更改		日
Acasti Pharma	USD 17.3M		3.22M	2025-09
Akebia Therapeutics	USD 243.48M		9.47M	2026-03
Alaunos Therapeutics	USD 970K		1.02M	2026-03
Aurora Cannabis	CAD 445.84M		22M	2025-12
Avita Medical	AUD 35.49M		760K	2025-12
Canopy Growth	CAD 524.67M		78.85M	2025-12
Cronos Group	USD 927.88M		16.21M	2026-03
Dianthus Therapeutics	USD 1.12B		710.47M	2026-03
Divis Laboratories Ltd	INR 98.43B		2.38B	2025-09
Ionis Pharmaceuticals	USD 2.94B		52M	2026-03
IQVIA Holdings	USD 6.22B		29M	2026-03
Knight Therapeutics	CAD 394.84M		5.86M	2025-12
Moderna	USD 5.77B		774M	2026-03
Organigram Holdings	CAD 256.54M		28.35M	2025-12
Organon & Co	USD 4.93B		580M	2026-03
Revvity	USD 2.13B		111.43M	2026-03
Tectonic Therapeutic	USD 239.89M		17.47M	2026-03
Tilray	USD 729.32M		28.18M	2025-09
Viatris	USD 10.92B		1.13B	2026-03
Xeris Pharmaceuticals	USD 251.68M		11.37M	2026-03
Zealand Pharma A/S	15.67B		950.94M	2025-12